Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan

NCT00517322 is registered in ClinicalTrials.gov with Università degli Studi dell'Insubria as lead sponsor.

NCT NCT00517322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00517322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan
Lead sponsor
Università degli Studi dell'Insubria
Phase
Phase 4
Overall status
Unknown status
Start date
August 31, 2007
Completion date
August 31, 2010
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antihypertensive drugs, diastolic function, hypertensive heart disease, left atrial volume, renin angiotensin system